Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1073

2.

Evaluation of a collagen-alginate wound dressing in the management of diabetic foot ulcers.

Donaghue VM, Chrzan JS, Rosenblum BI, Giurini JM, Habershaw GM, Veves A.

Adv Wound Care. 1998 May-Jun;11(3):114-9.

PMID:
9729942
3.

Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial.

Kakagia DD, Kazakos KJ, Xarchas KC, Karanikas M, Georgiadis GS, Tripsiannis G, Manolas C.

J Diabetes Complications. 2007 Nov-Dec;21(6):387-91.

PMID:
17967712
4.

[Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers].

Lázaro-Martínez JL, García-Morales E, Beneit-Montesinos JV, Martínez-de-Jesús FR, Aragón-Sánchez FJ.

Cir Esp. 2007 Jul;82(1):27-31. Spanish.

5.

Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

Veves A, Falanga V, Armstrong DG, Sabolinski ML; Apligraf Diabetic Foot Ulcer Study.

Diabetes Care. 2001 Feb;24(2):290-5.

PMID:
11213881
6.

Some effects of a topical collagen-based matrix on the microcirculation and wound healing in patients with chronic venous leg ulcers: preliminary observations.

Wollina U, Schmidt WD, Krönert C, Nelskamp C, Scheibe A, Fassler D.

Int J Low Extrem Wounds. 2005 Dec;4(4):214-24.

PMID:
16286373
7.

HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial.

Caravaggi C, De Giglio R, Pritelli C, Sommaria M, Dalla Noce S, Faglia E, Mantero M, Clerici G, Fratino P, Dalla Paola L, Mariani G, Mingardi R, Morabito A.

Diabetes Care. 2003 Oct;26(10):2853-9.

PMID:
14514591
8.

Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.

Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H.

J Diabetes Complications. 2006 Sep-Oct;20(5):329-35.

PMID:
16949521
9.

Apligraf in the treatment of neuropathic diabetic foot ulcers.

Edmonds M; European and Australian Apligraf Diabetic Foot Ulcer Study Group.

Int J Low Extrem Wounds. 2009 Mar;8(1):11-8. doi: 10.1177/1534734609331597. Epub 2009 Feb 3.

PMID:
19189997
10.

Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers.

Jude EB, Apelqvist J, Spraul M, Martini J; Silver Dressing Study Group.

Diabet Med. 2007 Mar;24(3):280-8.

PMID:
17305788
11.

Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries.

Ghatnekar O, Willis M, Persson U.

J Wound Care. 2002 Feb;11(2):70-4.

PMID:
11901743
12.

The healing properties of Promogran in venous leg ulcers.

Vin F, Teot L, Meaume S.

J Wound Care. 2002 Oct;11(9):335-41.

PMID:
12430368
13.
14.

Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.

Brem H, Balledux J, Bloom T, Kerstein MD, Hollier L.

Arch Surg. 2000 Jun;135(6):627-34.

PMID:
10843357
15.
16.

Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds.

McCallon SK, Knight CA, Valiulus JP, Cunningham MW, McCulloch JM, Farinas LP.

Ostomy Wound Manage. 2000 Aug;46(8):28-32, 34.

PMID:
11189545
17.

An alternative dressing material for the split-thickness skin graft donor site: oxidized regenerated cellulose.

Uysal AC, Alagoz MS, Orbay H, Sensoz O.

Ann Plast Surg. 2006 Jul;57(1):60-4.

PMID:
16799310
18.

A parallel open-label trial to evaluate microbial cellulose wound dressing in the treatment of diabetic foot ulcers.

Solway DR, Clark WA, Levinson DJ.

Int Wound J. 2011 Feb;8(1):69-73. doi: 10.1111/j.1742-481X.2010.00750.x. Epub 2010 Dec 16.

PMID:
21159127
19.
20.

Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers.

Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, Steed DP, Lipkin S.

Diabetes Care. 1996 Apr;19(4):350-4.

PMID:
8729158

Supplemental Content

Support Center